Alaunos Therapeutics, Inc. Common Stock — Rendiconto Finanziario Trimestrale (NASDAQ:TCRT) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 6.1597 M
Employee 1
Founded 1998
CEO N/A
Website www.alaunos.com
Headquarter Delaware, United States
FIGI BBG000FWCC57
Industry Biotecnologia

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

6.16 M Capitalizzazione di mercato

Rapporto prezzo/utili

-1.47

Rapporto prezzo/fatturato

1 258.64

Notizie

Alaunos Therapeutics riceve notifica dal Nasdaq per non conformità alle regole sul capitale

Rosso a Wall Street con il conflitto in Medio Oriente, caccia ai beni rifugio

Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop - Alaunos Therapeutics (NASDAQ:TCRT)

Alaunos pubblica dati preliminari sul farmaco anti-obesità da studi sui topi

Alaunos reports early obesity drug data from mouse studies

Alaunos Therapeutics raggiunge accordo con MD Anderson per fatture non pagate

Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices

Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Applied Digital (NASDAQ:APLD), Baosheng Media Gr (NASDAQ:BAOS)

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings - Galecto (NASDAQ:GLTO)

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Ambow Education Holding (AMEX:AMBO)

Alaunos Therapeutics regains Nasdaq compliance after equity increase

Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair